Intestinal permeability and complications in liver cirrhosis: A prospective cohort study

Hepatology Research

Volumn 43, Issue 2, 2013, Pages 200-207

  Benjamin, Jaya ^a   Singla, Vikas ^a   Arora, Indu ^a   Sood, Seema ^a   Joshi, Yogendra Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hepatic encephalopathy; Intestinal permeability; Lactulose mannitol ratio; Liver cirrhosis; Spontaneous bacterial peritonitis

Indexed keywords

ENDOTOXIN; LACTULOSE; MANNITOL;

ADULT; ARTICLE; BACTERIAL PERITONITIS; BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG FECES LEVEL; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; INTESTINE MUCOSA PERMEABILITY; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VARICOSIS;

EID: 84873960527     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01054.x     Document Type: Article

References (50)

1. Garcia-Tsao G, Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 2004; 18: 353-72.
2. Wiest R, Rath HC. Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 2003; 17: 397-425.
3. Misra V, Misra SP, Dwivedi M, Gupta SC. Histomorphometric study of portal hypertensive enteropathy. Am J Clin Pathol 1997; 108: 652-7.
4. Castilla-Cortazar I, Prieto J, Urdaneta E etal. Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I. Gastroenterology 1997; 113: 1180-7.
5. Unno N, Wang H, Menconi MJ etal. Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997; 113: 1246-57.
6. Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984; 1 (8370): 179-82.
7. Kalaitzakis E, Johansson JE, Bjarnason I, Björnsson E. Intestinal permeability in cirrhotic patients with and without ascites. Scand J Gastroenterol 2006; 41: 326-30.
8. Groszmann RJ. Hyperdynamic circulation of liver disease 40years later: pathophysiology and clinical consequences. Hepatology 1994; 20: 1359-63.
9. Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999; 11: 755-9.
10. Ersöz G, Aydin A, Erdem S, Yüksel D, Akarca U, Kumanlioglu K. Intestinal permeability in liver cirrhosis. Eur J Gastroenterol Hepatol 1999; 11: 409-12.
11. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
12. Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology 2004; 39: 841-56.
13. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-21.
14. Arroyo V, Gines P, Gerbes AL etal. Definition and diagnostic criteria of refractory ascites and hepato-renal syndrome in cirrhosis. Hepatology 1996; 23: 164-76.
15. Behrens RH, Docherty H, Elia M, Neale G. A simple enzymatic method for the assay of urinary lactulose. Clin Chim Acta 1984; 137: 361-7.
16. Corcoran A, Page J. A method for determination of mannitol in plasma and urine. J Biol Chem 1947; 170: 165-71.
17. Roe JH, Rice EW. A photometric method for the determination of free pentoses in animal tissues. J Biol Chem 1948; 173: 507-12.
18. Pascual S, Such J, Esteban A etal. Intestinal permeability is increased in patients with advanced cirrhosis. Hepatogastroenterology 2003; 50: 1482-6.
19. Resnick RH, Royal H, Marshall W, Barron R, Werth T. Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc] DTPA. Dig Dis Sci 1990; 35: 205-11.
20. Toh Y, Korenaga D, Maekawa S etal. Assessing the permeability of the gastrointestinal mucosa after oral administration of phenolsulfonphthalein. Hepatogastroenterology 1997; 44: 1147-51.
21. van Deventer SJ, Knepper A, Landsman J etal. Endotoxins in portal blood. Hepatogastroenterology 1988; 35: 223-5.
22. Fujii T, Seki T, Maruoka M etal. Lactulose-L-rhamnose intestinal permeability test in patients with liver cirrhosis. Hepatol Res 2001; 19: 158-69.
23. Budillon G, Parrilli G, Pacella M, Cuomo R, Menzies IS. Investigation of intestine and liver function in cirrhosis using combined sugar oral loads. J Hepatol 1985; 1: 513-24.
24. Romiti A, Merli M, Martorano M etal. Malabsorption and nutritional abnormalities in patients with liver cirrhosis. Ital J Gastroenterol 1990; 22: 118-23.
25. Bac DJ, Swart GR, van den Berg JWO, Willem P, Wilson JH. Small bowel wall function in patients with advanced liver cirrhosis and portal hypertension: studies on permeability and luminal bacterial overgrowth. Eur J Gastroenterol Hepatol 1993; 5: 383-7.
26. Huglo D, De Botton S, Canva-Delcambre V etal. Simultaneous determination of pulmonary and intestinal permeability in patients with alcoholic liver cirrhosis. Eur J Nucl Med 2001; 28: 1505-11.
27. Cariello R, Federico A, Sapone A etal. Intestinal permeability in patients with chronic liver diseases: it's relationship with the aetiology and the entity of liver damage. Dig Liver Dis 2010; 42: 200-4.
28. Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1984; i: 179-82.
29. Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol 1999; 94: 200-7.
30. Hollander D. Intestinal permeability in health and disease. In: Kirsner JB, ed. Inflammatory Bowel Disease. Philadelphia, PA: Saunders, 2000; 45-54.
31. Keshavarzian A, Fields JZ, Vaeth J, Holmes EW. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol 1994; 89: 2205-11.
32. Bijlsma PB, Peeters RA, Groot JA, Dekker PR, Taminiau JA, Van Der Meer R. Differential in vivo and in vitro intestinal permeability to lactulose and mannitol in animals and humans: a hypothesis. Gastroenterology 1995; 108: 687-96.
33. Xu WH, Wu XJ, Li JS. Influence of portal pressure change on intestinal permeability in patients with portal hypertension. Hepatobiliary Pancreat Dis Int 2002; 1: 510-14.
34. Enquist IF, Golding MR, Aiello RG, Fierst SM, Solomon NA. The effect of portal hypertension on intestinal absorption. Surg Gynecol Obstet 1965; 120: 87-91.
35. Marin GA, Clark ML, Senior JR. Distribution of d-xylose in sequestered fluid resulting in false-positive tests for malabsorption. Ann Intern Med 1968; 69: 1155-62.
36. Losowsky MS, Walker BE. Liver disease and malabsorption. Gastroenterology 1969; 56: 589-600.
37. Fuchs M, Pfeiffer A, Kuntzen O, Kaess H. Intestinal permeability in liver cirrhosis and spontaneous bacterial peritonitis. Gastroenterology 1997; 112: A1266.
38. Ferri M, Gabriel S, Gavelli A, Franconeri P, Huguet C. Bacterial translocation during portal clamping for liver resection. A clinical study. Arch Surg 1997; 132: 162-5.
39. Cirera I, Bauer TM, Navasa M etal. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001; 34: 32-7.
40. Ambrose NS, Johnson M, Burdon DW, Keighley MR. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery. Br J Surg 1984; 71: 623-5.
41. Deitch EA. Simple intestinal obstruction causes bacterial translocation in man. Arch Surg 1989; 124: 699-701.
42. O'Boyle CJ, MacFie J, Dave K, Sagar PS, Poon P, Mitchell CJ. Alterations in intestinal barrier function do not predispose to translocation of enteric bacteria in gastroenterologic patients. Nutrition 1998; 14: 358-62.
43. Kuzu MA, Kale IT, Cöl C, Tekeli A, Tanik A, Köksoy C. Obstructive jaundice promotes bacterial translocation in humans. Hepatogastroenterology 1999; 46: 2159-64.
44. Pardo A, Bartolí R, Lorenzo-Zúñiga V etal. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000; 31: 858-63.
45. Pérez-Paramo M, Muñoz J, Albillos A etal. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000; 31: 43-8.
46. García-Tsao G. Bacterial translocation: cause or consequence of decompensation in cirrhosis? J Hepatol 2001; 34: 150-5.
47. Zuckerman MJ, Menzies IS, Ho H etal. Assessment of intestinal permeability and absorption in cirrhotic patients with ascites using combined sugar probes. Dig Dis Sci 2004; 49: 621-6.
48. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984; 4: 53-8.
49. Morencos FC, de las Heras Castaño G, Martín Ramos L, López Arias MJ, Ledesma F, Pons Romero F. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1995; 40: 1252-6.
50. Yang CY, Chang CS, Chen GH. Small-intestinal bacterial overgrowth in patients with liver cirrhosis, diagnosed with glucose H2 or CH4 breath tests. Scand J Gastroenterol 1998; 33: 867-71.